The Brand Name LIDOPATCH Has Generic Salt :: Lidocaine 

LIDOPATCH  Is From Company Zydus Cad. Priced :: Rs. 130

LIDOPATCH have Lidocaine is comes under Sub class Anti Arrhythmics of  Main Class Cardiovascular System

Main Medicine Class:: Cardiovascular System  Sub Medicine Class :: Anti Arrhythmics 

Indications for Drugs ::

Local anaesthesia

Drug Dose ::

Adult: Topical As eutectic mixture containing lidocaine base 2.5% and prilocaine base 2.5%: For minor procedures: Apply 2.5 g over 20-25 cm2 of skin surface for at least 1 hr. For major dermal procedures involving a larger skin area: Apply 2 g per 10 cm2 of skin and allow to remain in contact with the skin for at least 2 hr. As adjunct to local infiltration anesth in genital mucous membranes: Apply 1 g per 10 cm2 of the skin surface for 15 mins. For superficial minor surgery of genital mucous membranes in adult females: Apply 5-10 g for 5-10 mins.

Contraindication ::

Neonates with gestational age <37 wk. Infants <12 mth of age who are receiving treatment with methaemoglobin-inducing agents or children who are receiving medications associated with drug-induced methaemoglobinemia. Children with congenital or idiopathic methaemoglobinemia. Application on mucous membranes, broken or inflamed skin. Drug Precautions ::

Caution when used over large areas and leaving on for >2 hr. Severe hepatic impairment. Caution when used in patients who are receiving class I and III antiarrhythmics. Dose reduction may be necessary in acutely ill, debilitated patients and elderly. Avoid using on open wounds or near the eyes. Pregnancy and lactation.

Drug Side Effects ::

Hyperpigmentation, erythema, itching, rash, burning, urticaria, stinging, oedema.

Pregnancy category ::

2

Drug Mode of Action ::  

Lidocaine and prilocaine are local anaesthetic agents of the amide type. Both work by stabilising the neuronal membranes and inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby giving rise to the anaesthetic action.

Drug Interactions ::

Increased risk of toxicity when used with drugs that are known to cause methaemoglobinaemia. Concurrent use with class III antiarrhythmics may lead to additive cardiac effects. Toxic effects may be additive when used with class I antiarrhythmics.